Company Filing History:
2 out of 2,088 
1 out of 3 
1 out of 4 Years Active: 1996-1997
Title: Jozef Oleksyszyn: Innovator in Pharmaceutical Chemistry
Introduction
Jozef Oleksyszyn is a notable inventor based in Arlington, MA (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of four patents that focus on innovative compounds with significant therapeutic potential. His work primarily revolves around the development of agents that can inhibit specific enzymes related to various diseases.
Latest Patents
Among his latest patents, Oleksyszyn has developed basic α-aminoalkylphosphonate derivatives. These peptidyl derivatives of diesters of α-aminoalkylphosphonic acids are designed to inhibit serine proteases with trypsin-like specificity. They also serve as anti-inflammatory agents, anticoagulants, and anti-tumor agents. Another significant patent involves amino acid amides of 1,3,4-thiadiazoles, which are disclosed as inhibitors of matrix metalloproteinase enzymes. These compounds are particularly relevant for treating diseases caused by the over-activity of matrix metalloproteinases, such as osteoarthritis and rheumatoid arthritis.
Career Highlights
Throughout his career, Jozef Oleksyszyn has worked with esteemed organizations, including Georgia Tech Research Corporation and Osteoarthritis Sciences, Inc. His research has led to advancements in understanding and treating conditions related to enzyme activity, showcasing his commitment to improving patient outcomes.
Collaborations
Oleksyszyn has collaborated with notable professionals in his field, including James C. Powers and Bogdan Boduszek. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his inventions.
Conclusion
Jozef Oleksyszyn's innovative work in pharmaceutical chemistry has led to the development of important therapeutic agents. His patents reflect a dedication to addressing significant health challenges through scientific research and collaboration.